<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: In Mexico during 2008, were reported 127,604 new <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases, 6,347 of them were <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases and 4,276 non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) cases </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To evaluate health related quality of life in non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases in different clinical stages, attended in a High Specialty Medical facility at the Instituto Mexicano del Seguro Social, during a 13 month period </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: 162 patients were included, 56.8% (n=92) with NHL and 43.2% (n=70) with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The scores obtained in the NHL group were: Global health status/QoL: 67.75 (± 27.55), physical functioning 69.64 (± 29.98), role functioning 71.38 (± 33.73), emotional functioning 69.7 (± 26.57), cognitive functioning 75.36 (± 28.01), social functioning 79.35 (± 29.38), <z:mp ids='MP_0002899'>fatigue</z:mp> 35.27 (± 28.27), <z:hpo ids='HP_0002017'>nausea and vomiting</z:hpo> 13.41 (± 21.85), pain 28.08 (± 30.25), <z:hpo ids='HP_0002094'>dyspnea</z:hpo> 19.20 (± 32.11), <z:hpo ids='HP_0100785'>insomnia</z:hpo> 30.80 (± 38.03), appetite lost 26.45 (± 36.16), <z:hpo ids='HP_0002019'>constipation</z:hpo> 19.20 (± 32.11), <z:hpo ids='HP_0002014'>diarrhea</z:hpo> 12.32 (± 26.48), financial difficulties 26.09 (± 35.57) </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients the scores were: Global health status/QoL: 68.21 (± 24.46), physical functioning 67.38 (± 30.45), role functioning 65.48 (± 35.70), emotional functioning 66.43 (± 26.84), cognitive functioning 78.57 (± 26.49), social functioning 75.24 (± 31.05), <z:mp ids='MP_0002899'>fatigue</z:mp> 37.78 (± 31.62), <z:hpo ids='HP_0002017'>nausea and vomiting</z:hpo> 20.00 (± 28.32), pain 37.38 (± 34.45), <z:hpo ids='HP_0002094'>dyspnea</z:hpo> 11.90 (± 26.64), <z:hpo ids='HP_0100785'>insomnia</z:hpo> 28.09 (± 35.73), appetite lost 23.81 (± 36.40), <z:hpo ids='HP_0002019'>constipation</z:hpo> 19.05 (± 32.88), <z:hpo ids='HP_0002014'>diarrhea</z:hpo> 20.95 (± 31.17), financial difficulties 34.76 (± 38.67) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: With these basal results is important a follow-up with special attention to the treatment and attendance processes, in patients with this <z:hpo ids='HP_0002664'>neoplasms</z:hpo> and their impact on the quality of life </plain></SENT>
</text></document>